trimethoprim has been researched along with Primary Peritonitis in 14 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The extensive use of invasive procedures and of long-term norfloxacin prophylaxis in the management of cirrhotic patients may have influenced the epidemiology of bacterial infections in cirrhosis." | 7.71 | Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. ( Arroyo, V; Colmenero, J; Fernández, J; Gómez, J; Navasa, M; Rodés, J; Vila, J, 2002) |
| "Trimethoprim-sulfadiazine and gentamicin sulfate decreased early mortality in an established model of fibrinous peritonitis in the rat." | 7.67 | Efficacies of trimethoprim-sulfadiazine and gentamicin sulfate in the treatment of fibrinous peritonitis in rats. ( Benson, CE; Emms, SG, 1987) |
| " The dosage yielded too high plasma trimethoprim concentrations, while sulfamethoxazole dialysate concentrations were too low." | 5.27 | Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis. ( Berden, JH; Hekster, YA; Martea, M; Voets, AJ; Vree, TB, 1987) |
| "Vancomycin was found to be appropriate in particular because of the resistance characteristics of bacterial isolates." | 5.27 | [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin]. ( Binswanger, U; König, U; Müller, U, 1987) |
| "The extensive use of invasive procedures and of long-term norfloxacin prophylaxis in the management of cirrhotic patients may have influenced the epidemiology of bacterial infections in cirrhosis." | 3.71 | Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. ( Arroyo, V; Colmenero, J; Fernández, J; Gómez, J; Navasa, M; Rodés, J; Vila, J, 2002) |
| "Trimethoprim-sulfadiazine and gentamicin sulfate decreased early mortality in an established model of fibrinous peritonitis in the rat." | 3.67 | Efficacies of trimethoprim-sulfadiazine and gentamicin sulfate in the treatment of fibrinous peritonitis in rats. ( Benson, CE; Emms, SG, 1987) |
| "It is concluded that initial treatment of CAPD peritonitis with co-trimoxazole is justified by the high proportion of sensitive germs and that it represents a safe, efficient and inexpensive treatment." | 1.27 | Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole. ( Favre, H; Glasson, P, 1984) |
| " The dosage yielded too high plasma trimethoprim concentrations, while sulfamethoxazole dialysate concentrations were too low." | 1.27 | Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis. ( Berden, JH; Hekster, YA; Martea, M; Voets, AJ; Vree, TB, 1987) |
| "Vancomycin was found to be appropriate in particular because of the resistance characteristics of bacterial isolates." | 1.27 | [Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin]. ( Binswanger, U; König, U; Müller, U, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (78.57) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Glasson, P | 1 |
| Favre, H | 1 |
| Winslow, DL | 1 |
| Steele, ML | 1 |
| de Fremont, JF | 1 |
| Schmit, JL | 1 |
| Thomas, D | 1 |
| Coevoet, B | 1 |
| Eb, F | 1 |
| Laurence, G | 1 |
| Orfila, J | 1 |
| Fournier, A | 1 |
| Singlas, E | 1 |
| Colin, JN | 1 |
| Rottembourg, J | 1 |
| Meessen, JP | 1 |
| de Martin, A | 1 |
| Legrain, M | 1 |
| Simon, P | 1 |
| Tilgner, SL | 1 |
| Anstey, SI | 1 |
| Fernández, J | 1 |
| Navasa, M | 1 |
| Gómez, J | 1 |
| Colmenero, J | 1 |
| Vila, J | 1 |
| Arroyo, V | 1 |
| Rodés, J | 1 |
| Tally, FP | 1 |
| Gorbach, SL | 1 |
| Goris, RJ | 2 |
| van Bebber, IP | 2 |
| Mollen, RM | 2 |
| Koopman, JP | 2 |
| Morris, AJ | 1 |
| Henderson, GK | 1 |
| Bremner, DA | 1 |
| Collins, JF | 1 |
| Martea, M | 1 |
| Hekster, YA | 1 |
| Vree, TB | 1 |
| Voets, AJ | 1 |
| Berden, JH | 1 |
| König, U | 1 |
| Müller, U | 1 |
| Binswanger, U | 1 |
| Höllwarth, M | 1 |
| Graf, D | 1 |
| Kurz, R | 1 |
| Sauer, H | 1 |
| Emms, SG | 1 |
| Benson, CE | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Patterns of Antibiotic Resistant Bacterial Infections in Liver Intensive Care Unit[NCT03855709] | 200 participants (Anticipated) | Observational | 2019-05-31 | Not yet recruiting | |||
| Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis in Patients With Acute Variceal Bleeding[NCT00838864] | Phase 4 | 79 participants (Actual) | Interventional | 2009-03-31 | Completed | ||
| Comparison of Daily Norfloxacin Versus Weekly Ciprofloxacin for the Prevention of Spontaneous Bacterial Peritonitis in Cirrhotic Patients[NCT01542801] | Phase 4 | 124 participants (Actual) | Interventional | 2011-08-31 | Completed | ||
| Rifaximin Versus Norfloxacin in the Primary Prophylaxis of Spontaneous Bacterial Peritonitis[NCT04159870] | Phase 3 | 322 participants (Anticipated) | Interventional | 2019-11-05 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for trimethoprim and Primary Peritonitis
| Article | Year |
|---|---|
Antibiotics in surgery.
Topics: Anti-Bacterial Agents; Bacterial Infections; Biliary Tract Diseases; Burns; Catheterization; Cephalo | 1975 |
1 trial available for trimethoprim and Primary Peritonitis
| Article | Year |
|---|---|
[Antibiotic treatment of perforated appendicitis in childhood--a prospective study].
Topics: Anti-Bacterial Agents; Appendectomy; Appendicitis; Child; Clinical Trials as Topic; Drug Combination | 1986 |
12 other studies available for trimethoprim and Primary Peritonitis
| Article | Year |
|---|---|
Treatment of peritonitis in continuous ambulatory peritoneal dialysis patients with co-trimoxazole.
Topics: Adult; Aged; Anti-Infective Agents, Urinary; Bacterial Infections; Drug Combinations; Female; Humans | 1984 |
Listeria bacteremia and peritonitis associated with a peritoneovenous shunt: successful treatment with sulfamethoxazole and trimethoprim.
Topics: Aged; Humans; Listeriosis; Male; Peritoneovenous Shunt; Peritonitis; Postoperative Complications; Se | 1984 |
[Treatment of peritonitis in continuous ambulatory peritoneal dialysis ].
Topics: Adult; Aged; Amphotericin B; Anti-Bacterial Agents; Candidiasis; Drug Combinations; Humans; Kidney F | 1982 |
Pharmacokinetics of sulfamethoxazole--trimethoprim combination during chronic peritoneal dialysis: effect of peritonitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Drug Combinations; Female; Humans; Kidney Failure, Ch | 1982 |
Nocardial peritonitis in a cat.
Topics: Animals; Anti-Infective Agents; Cat Diseases; Cats; Combined Modality Therapy; Drainage; Fluid Thera | 1996 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis.
Topics: Aged; Anti-Infective Agents; Bacterial Infections; Critical Care; Drug Resistance, Microbial; Escher | 2002 |
Does selective decontamination of the gastrointestinal tract prevent multiple organ failure? An experimental study.
Topics: Animals; Digestive System; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Lymph Nodes; Ma | 1991 |
Decontamination of the gastrointestinal tract and prevention of multiple organ failure. An experimental study.
Topics: Animals; Digestive System; Disinfection; Enterobacteriaceae; Male; Multiple Organ Failure; Peritonit | 1989 |
Relapsing peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis due to Corynebacterium aquaticum.
Topics: Adult; Anti-Bacterial Agents; Corynebacterium; Corynebacterium Infections; Diabetic Nephropathies; D | 1986 |
Pharmacokinetics of cefradine, sulfamethoxazole and trimethoprim and their metabolites in a patient with peritonitis undergoing continuous ambulatory peritoneal dialysis.
Topics: Anti-Infective Agents, Urinary; Cephalosporins; Cephradine; Drug Combinations; Half-Life; Humans; Ki | 1987 |
[Treatment of peritonitis during continuous ambulatory peritoneal dialysis (CAPD) with co-trimoxazole, cefazolin or vancomycin].
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Aspergillus; Bacteria; Candida; Cefazolin; Drug Combin | 1987 |
Efficacies of trimethoprim-sulfadiazine and gentamicin sulfate in the treatment of fibrinous peritonitis in rats.
Topics: Animals; Disease Models, Animal; Drug Combinations; Gentamicins; Male; Peritonitis; Rats; Rats, Inbr | 1987 |